Annual Net Income
-$80.05 M
-$5.29 M-7.07%
31 December 2021
Summary:
Concert Pharmaceuticals annual net profit is currently -$80.05 million, with the most recent change of -$5.29 million (-7.07%) on 31 December 2021. During the last 3 years, it has fallen by -$5.29 million (-7.07%).CNCE Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$28.90 M
-$5.36 M-22.75%
30 September 2022
Summary:
Concert Pharmaceuticals quarterly net profit is currently -$28.90 million, with the most recent change of -$5.36 million (-22.75%) on 30 September 2022.CNCE Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$126.31 M
-$2.23 M-1.79%
30 September 2022
Summary:
Concert Pharmaceuticals TTM net profit is currently -$126.31 million, with the most recent change of -$2.23 million (-1.79%) on 30 September 2022.CNCE TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNCE Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -7.1% | -8.3% | -90.5% |
| 5 y5 years | -42.9% | -68.2% | -60.9% |
CNCE Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -183.7% | -122.6% | -220.9% |
Concert Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$28.90 M(+22.7%) | -$126.31 M(+1.8%) |
| June 2022 | - | -$23.55 M(-37.6%) | -$124.08 M(+30.5%) |
| Mar 2022 | - | -$37.73 M(+4.4%) | -$95.11 M(+18.8%) |
| Dec 2021 | -$80.05 M(+7.1%) | -$36.13 M(+35.4%) | -$80.05 M(+20.7%) |
| Sept 2021 | - | -$26.68 M(-591.8%) | -$66.31 M(+13.3%) |
| June 2021 | - | $5.42 M(-123.9%) | -$58.54 M(-23.9%) |
| Mar 2021 | - | -$22.67 M(+1.2%) | -$76.96 M(+2.9%) |
| Dec 2020 | -$74.77 M(-4.3%) | -$22.39 M(+18.4%) | -$74.77 M(+2.6%) |
| Sept 2020 | - | -$18.91 M(+45.5%) | -$72.86 M(+2.4%) |
| June 2020 | - | -$12.99 M(-36.6%) | -$71.14 M(-7.4%) |
| Mar 2020 | - | -$20.48 M(-0.0%) | -$76.82 M(-1.7%) |
| Dec 2019 | -$78.17 M(+39.5%) | -$20.49 M(+19.2%) | -$78.17 M(-0.5%) |
| Sept 2019 | - | -$17.18 M(-7.9%) | -$78.53 M(-0.3%) |
| June 2019 | - | -$18.67 M(-14.5%) | -$78.73 M(+7.3%) |
| Mar 2019 | - | -$21.83 M(+4.7%) | -$73.39 M(+31.0%) |
| Dec 2018 | -$56.02 M(-158.6%) | -$20.85 M(+19.9%) | -$56.02 M(+35.8%) |
| Sept 2018 | - | -$17.39 M(+30.5%) | -$41.24 M(-139.6%) |
| June 2018 | - | -$13.32 M(+198.6%) | $104.21 M(-0.3%) |
| Mar 2018 | - | -$4.46 M(-26.4%) | $104.51 M(+9.3%) |
| Dec 2017 | $95.64 M | -$6.07 M(-104.7%) | $95.64 M(+6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | $128.06 M(-1083.1%) | $89.66 M(-280.2%) |
| June 2017 | - | -$13.03 M(-2.3%) | -$49.76 M(-0.8%) |
| Mar 2017 | - | -$13.33 M(+10.7%) | -$50.17 M(-1.1%) |
| Dec 2016 | -$50.72 M(-309.8%) | -$12.04 M(+6.0%) | -$50.72 M(+33.5%) |
| Sept 2016 | - | -$11.36 M(-15.5%) | -$37.99 M(+8.0%) |
| June 2016 | - | -$13.44 M(-3.2%) | -$35.19 M(-282.4%) |
| Mar 2016 | - | -$13.88 M(-2129.2%) | $19.30 M(-20.2%) |
| Dec 2015 | $24.17 M(-176.3%) | $684.00 K(-108.0%) | $24.17 M(+66.0%) |
| Sept 2015 | - | -$8.55 M(-120.8%) | $14.56 M(-4.7%) |
| June 2015 | - | $41.05 M(-556.0%) | $15.29 M(-145.3%) |
| Mar 2015 | - | -$9.00 M(+0.8%) | -$33.75 M(+6.5%) |
| Dec 2014 | -$31.70 M(+423.4%) | -$8.93 M(+14.0%) | -$31.70 M(+10.5%) |
| Sept 2014 | - | -$7.83 M(-2.0%) | -$28.69 M(+2.5%) |
| June 2014 | - | -$7.99 M(+15.0%) | -$27.98 M(+149.2%) |
| Mar 2014 | - | -$6.95 M(+17.5%) | -$11.23 M(+85.4%) |
| Dec 2013 | -$6.06 M(-70.4%) | -$5.92 M(-17.0%) | -$6.06 M(-23.3%) |
| Sept 2013 | - | -$7.13 M(-181.3%) | -$7.90 M(+922.0%) |
| June 2013 | - | $8.77 M(-592.7%) | -$773.00 K(-91.9%) |
| Mar 2013 | - | -$1.78 M(-77.1%) | -$9.54 M(+22.9%) |
| Dec 2012 | -$20.44 M(+80.6%) | -$7.76 M | -$7.76 M |
| Dec 2011 | -$11.32 M | - | - |
FAQ
- What is Concert Pharmaceuticals annual net profit?
- What is the all time high annual net income for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Concert Pharmaceuticals?
What is Concert Pharmaceuticals annual net profit?
The current annual net income of CNCE is -$80.05 M
What is the all time high annual net income for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high annual net profit is $95.64 M
What is Concert Pharmaceuticals quarterly net profit?
The current quarterly net income of CNCE is -$28.90 M
What is the all time high quarterly net income for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high quarterly net profit is $128.06 M
What is Concert Pharmaceuticals TTM net profit?
The current TTM net income of CNCE is -$126.31 M
What is the all time high TTM net income for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high TTM net profit is $104.51 M